IRIDEX (NASDAQ:IRIX) & Mindray Medical International (MR) Head to Head Survey

IRIDEX (NASDAQ: IRIX) and Mindray Medical International (NYSE:MR) are both computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, institutional ownership, valuation, dividends, analyst recommendations, earnings and profitability.

Insider and Institutional Ownership

49.3% of IRIDEX shares are held by institutional investors. 5.0% of IRIDEX shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Valuation and Earnings

This table compares IRIDEX and Mindray Medical International’s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
IRIDEX $46.16 million 2.09 -$11.71 million ($1.71) -4.87
Mindray Medical International N/A N/A N/A $1.49 18.75

Mindray Medical International has lower revenue, but higher earnings than IRIDEX. IRIDEX is trading at a lower price-to-earnings ratio than Mindray Medical International, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for IRIDEX and Mindray Medical International, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
IRIDEX 0 0 1 0 3.00
Mindray Medical International 0 0 0 0 N/A

IRIDEX currently has a consensus target price of $13.00, indicating a potential upside of 56.06%. Given IRIDEX’s higher possible upside, research analysts clearly believe IRIDEX is more favorable than Mindray Medical International.

Dividends

Mindray Medical International pays an annual dividend of $0.36 per share and has a dividend yield of 1.3%. IRIDEX does not pay a dividend. Mindray Medical International pays out 24.2% of its earnings in the form of a dividend.

Profitability

This table compares IRIDEX and Mindray Medical International’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
IRIDEX -42.22% -23.21% -19.03%
Mindray Medical International 15.93% 12.70% 8.37%

Summary

IRIDEX beats Mindray Medical International on 6 of the 11 factors compared between the two stocks.

IRIDEX Company Profile

IRIDEX Corporation is a provider of therapeutic based laser consoles, delivery devices and consumable instrumentation used to treat sight-threatening eye diseases in ophthalmology. The Company operates through ophthalmology segment. Its ophthalmology products consist of laser consoles, delivery devices and consumable instrumentation, including laser probes, and are used in the treatment of serious eye diseases, including the over three causes of irreversible blindness, such as diabetic retinopathy, glaucoma and age-related macular degeneration (AMD). In addition, the Company’s ophthalmology products are often used in vitrectomy procedures (used to treat proliferative diabetic retinopathy, macular holes, retinal tears and detachments), which are generally performed in the operating room and require a consumable single use intraocular laser probe (EndoProbe) to deliver light to the back of the eye together with other instrumentation.

Mindray Medical International Company Profile

Mindray Medical International Limited is a developer, manufacturer and marketer of medical devices across the world. The Company operates in three segments: patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. Its patient monitoring devices track the physiological parameters of patients, such as heart rate, blood pressure, respiration and temperature. It offers patient monitoring devices that are suitable for adult, pediatric and neonatal patients and are used principally in hospital intensive care units, operating rooms and emergency rooms. Its life support products provide operation room or intensive care unit solutions for the end users in the operating room. Its in-vitro diagnostic products provide data and analysis on blood, urine and other bodily fluid samples for clinical diagnosis and treatment. Its medical imaging systems segment includes ultrasound systems, digital radiography systems and a magnetic resonance imaging system.

Receive News & Ratings for IRIDEX Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IRIDEX Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply